Disclaimer: We may earn a commission if you make any purchase by clicking our links. Please see our detailed guide here.

Follow us on:

Google News
Whatsapp

Some arthritis may be caused by mosquito-borne viruses

IANS
IANS
Meet the voice behind Indo-Asian News Service (IANS), a storyteller navigating the currents of global events with precision and depth. Crafting narratives that bridge cultures, IANS brings you the pulse of the world in every word

Join the Opinion Leaders Network

Join the Techgenyz Opinion Leaders Network today and become part of a vibrant community of change-makers. Together, we can create a brighter future by shaping opinions, driving conversations, and transforming ideas into reality.

Some therapies that are successful in treating rheumatoid arthritis (RA) may help improve treatment for people with debilitating mosquito-borne viral diseases, new research has found.

Infection caused by Chikungunya virus (CHIKV) and Ross River virus (RRV) are transmitted by mosquitoes and cause severe arthritis, muscle pain, and fever.

The disease caused by these viral infections bears several similarities with a form of auto-immune arthritis known as Rheumatoid Arthritis (RA), – lead author Ali Zaid from Menzies Health Institute Queensland at Griffith University in Australia.

“In severe RA, patients express high levels of an immune molecule called Interleukin-17 (IL-17), which is a target of new anti-arthritis drugs,” Zaid added.

In two new studies, published in the journals PLoS Pathogens and mBio, the researchers found IL-17 was also elevated during RRV and CHIKV infections.

The team analyzed serum samples from CHIKV-infected patients collected during the 2019 outbreak in northern Brazil.

They found that IL-17 levels were elevated in patients with acute disease, and more so in patients with chronic disease.

When we looked at serum samples from Ross River virus patients, levels of IL-17 were also elevated, which prompted us to ask whether this molecule was driving disease, – Helen Mostafavi, from Griffith.

Using an experimental mouse model of viral arthritis, they found that targeting IL-17 in virus-infected mice improved disease and reduced inflammation.

“This suggests that some therapies successful in treating RA could be of potential benefit to treat people with alphavirus disease,” Mostafavi said.

However, the authors found that a complete lack of IL-17 was not necessarily ideal: genetically modified mice that lack IL-17 showed an increase in viral RNA in the post-acute phase of disease — despite showing reduced inflammation.

In a separate study published in mBio, the authors investigated the role of a protein called TRIF, which cells use to “sense” viral RNA and start a strong antiviral response, which alerts neighboring cells.

Using genetically modified mice that lack the TRIF protein, the authors found that TRIF was needed to help generate neutralizing antibodies against RRV.

“These findings give new insights into how different arms of the immune response cooperate to ensure long-lasting defence against viruses like CHIKV and RRV and will pave the way into the development of new immunotherapies to treat these diseases,” the researchers said.

Join 10,000+ Fellow Readers

Get Techgenyz’s roundup delivered to your inbox curated with the most important for you that keeps you updated about the future tech, mobile, space, gaming, business and more.

Recomended

Partner With Us

Digital advertising offers a way for your business to reach out and make much-needed connections with your audience in a meaningful way. Advertising on Techgenyz will help you build brand awareness, increase website traffic, generate qualified leads, and grow your business.

Power Your Business

Solutions you need to super charge your business and drive growth

More from this topic